Recombinant Yeast Biosynthesis of Enantiomerically Pure Alpha-Ionone

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for producing α-ionone are unsatisfactory due to chemical synthesis producing a racemic mixture, environmental concerns, and the use of potentially harmful bacteria in de novo systems, while direct extraction from natural sources is inefficient and costly.

Innovation Solution

Development of recombinant microorganisms with nucleic acid constructs encoding lycopene cyclase and carotenoid cleavage dioxygenase enzymes to produce enantiomerically pure (R)(+)-α-ionone, using safe enzymes from organisms like Lactuca sativa and Daucus carota, which are operably linked to expression control sequences, allowing for efficient production of α-ionone without the concomitant production of β-ionone.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If chemical synthesis is used to produce α-ionone, then production volume and market availability are improved, but product purity (racemic mixture) and environmental sustainability deteriorate

Engineering Contradiction:

Improveproduction volumeVSAvoidenantiomer purity

Core Design Contradiction:

ProductivityVSManufacturing precision

Solution Approach 1:

The patent replaces chemical synthesis methods with microbial fermentation using recombinant yeast (Yarrowia lipolytica). The chemical synthesis process is substituted by a biological system that produces enantiomerically pure (R)-α-ionone through enzymatic pathways, eliminating the need for complex separation of racemic mixtures while maintaining high production volumes.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent modifies the production system by changing from chemical synthesis parameters to microbial fermentation parameters. By altering the fundamental production mechanism and using genetically engineered microorganisms with specific enzymatic pathways, the system achieves enantiomerically pure product formation while maintaining scalability and production efficiency.

Inventive Principle:

Principle #35Parameter changes

2Productivity

If chemical synthesis is used to produce α-ionone, then production volume is improved, but environmental sustainability and consumer acceptance deteriorate

Engineering Contradiction:

Improveproduction volumeVSAvoidenvironmental sustainability

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent substitutes the chemically intensive synthesis process with a biological fermentation system using recombinant yeast. This replacement eliminates harmful chemical byproducts, reduces environmental pollution, and aligns with consumer demand for naturally produced compounds, while maintaining high production volumes through scalable microbial culture processes.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Manufacturing precision

If direct extraction from natural sources is used to produce α-ionone, then product purity is improved, but production efficiency and cost-effectiveness deteriorate

Engineering Contradiction:

Improveenantiomer purityVSAvoidproduction efficiency

Core Design Contradiction:

Manufacturing precisionVSProductivity

Solution Approach 1:

The patent creates a microbial system that copies and amplifies the natural biosynthetic pathway found in plants. By transferring the enzymatic genes (crtB, crtI, and others) into yeast cells, the system reproduces the natural production of enantiomerically pure (R)-α-ionone while achieving much higher yields and production efficiencies compared to direct extraction from plant sources.

Inventive Principle:

Principle #26Copying

Solution Approach 2:

The patent replaces the mechanical extraction process with a biological synthesis system. Instead of extracting α-ionone from plant materials through tedious physical processes, the system uses microbial fermentation to synthesize the compound directly, achieving both high purity and high production efficiency simultaneously.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

4Manufacturing precision

If de novo biotechnological transformation using Pantoea ananatis enzymes is used to produce α-ionone, then enantiomer purity is improved, but safety and regulatory acceptance deteriorate

Engineering Contradiction:

Improveenantiomer purityVSAvoidbiological safety

Core Design Contradiction:

Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The patent uses Yarrowia lipolytica as an intermediary host organism to express the α-ionone biosynthesis enzymes. This intermediary system allows the production of enantiomerically pure (R)-α-ionone while avoiding the use of potentially harmful Pantoea ananatis enzymes directly in food or medical applications. The recombinant yeast system serves as a safe intermediary that produces the desired compound without the safety concerns associated with the original enzyme source.

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The recombinant microorganisms enable the production of enantiomerically pure (R)(+)-α-ionone, providing a natural, safe alternative to chemical synthesis with improved yield and environmental sustainability.

Implementation Method 1

recombinant microorganisms with nucleic acid constructs encoding lycopene cyclase and carotenoid cleavage dioxygenase enzymes to produce enantiomerically pure (R)(+)-α-ionone

Methodology Applied

Scientific EffectEnzyme catalysis: Enzyme